Assessing Function and Performance of Population Sexual Orientation and Gender Identity (SOGI) Research Measures in a Racially Diverse HIV-Specific National Cohort
Assessing Function and Performance of Population Sexual Orientation and Gender Identity (SOGI) Research Measures in a Racially Diverse HIV-Specific National Cohort
批准号:
10334307
负责人:
Bradley E Aouizerat
金额:
$9.98万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2026-03-31
关键词:
AIDS preventionAddressAreaBisexualCohort StudiesCommunicationDataData CollectionEthnic OriginFeeling suicidalFundingGenderGender IdentityGeographic LocationsGeographyGoalsHIVHIV SeronegativityHIV SeropositivityHealthHealthcareHomophobiaIndividualInstitute of Medicine (U.S.)LatinxLeadLesbianLoveMalignant NeoplasmsMeasurementMeasuresMedicalMental HealthMethodologyMinority GroupsNational Heart, Lung, and Blood InstituteNot Hispanic or LatinoObesityOutcomeParticipantPatientsPerformancePersonal SatisfactionPoliciesPopulationPopulation HeterogeneityPopulation ResearchPreventionPrevention ResearchProcessProspective cohortRaceResearchResearch PersonnelResearch PriorityRiskSamplingSex DifferentiationSex OrientationSexual HealthSexual and Gender MinoritiesSexually Transmitted DiseasesSmokingStandardizationSuicide attemptSurveysTestingUnited States National Academy of SciencesUnited States National Institutes of HealthWomancohortdata infrastructureethnic differenceethnic diversityexperiencefluidityfollow-upgenderqueerhealth differencehealth disparityimprovedmen who have sex with menminority communitiespansexualparent grantpreventracial and ethnicracial diversityracismrecruitresponsescreeningsocial stigmatransgender mentransgender womentransmission processtransphobiatreatment researchtwo spirit
中文摘要
项目摘要/摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
Sexual and gender minority (SGM) people have higher rates of HIV and other sexually transmitted infections,
suicidal ideation and attempts, obesity, cancer, poor mental health, and smoking and are at increased risk for
poor health outcomes compared to non-SGM people. Yet how these disparities might be mitigated and
prevented is unclear, in part because research among SGM populations suffers from challenges in capturing
sexual orientation and gender identity (SOGI). These challenges include the ability to achieve accuracy when
collected and to use questions that resonate and are understood by both SGM and non-SGM people. The
existing evidence on accurately capturing SGM status lacks racial/ethnic diversity and skews toward mostly
white SGM samples. Further, HIV prevention and treatment research efforts have evolved to target “key
populations,” such as men who have sex with men (MSM) and transgender women who are at elevated risk for
HIV transmission and acquisition. Transgender women and MSM, therefore, may be more familiar with survey
questions that seek to assess SOGI than other SGM individuals and groups considered less at risk for HIV
(e.g., lesbians, bisexual women, transgender men, non-binary people). Additionally, transphobia and
homophobia are often experienced in and can contribute to a context of HIV stigma and may impact the ways
in which SGM status is perceived and captured in HIV-specific settings. The intersections of racism and
transphobia and/or homophobia can exacerbate HIV-related stigma, also contributing to measurement hurdles.
Differences in the ways in which SGM individuals identify across US regions and cultures represent another
barrier to capturing accurate SGM status in data collection. To determine the best way to differentiate SGM
people from non-SGM people in population research, it is essential to assess such measures in
racially/ethnically diverse populations and unique contexts. This supplement leverages the data and
infrastructure of two NIH-funded studies (parent grant: U01HL146242; PI: Tien and R21MD015878; PI:
Obedin-Maliver) with the primary goal of expanding measurement testing to the MACS-WIHS Combined
Cohort Study, a prospective cohort of geographically and racially/ethnically diverse individuals living with or at
risk of HIV in the US. This supplement's aims are to: (1) Assess the function and performance of an SGM
status screening question and SOGI question sets in a racially/ethnically diverse US cohort of people living
with or at risk for HIV via the MWCCS; and (2) Determine the function and performance among SGM and non-
SGM people who are (a) HIV-negative and HIV-positive and (b) in HIV-specific and non-HIV-specific study
settings in the MWCCS, The Population Research in Identities and Disparities for Equality (PRIDE) Study, and
the Health eHeart (HeH) Study. The aims of this supplement are aligned with NHLBI's objective to “investigate
factors that account for differences in health among populations” and NIH SGM high priority research areas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteomic Profiling of Cardiac Dysfunction in the MACS-WIHS Combined Cohort Study
-
批准号:10658720
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:10202118
-
项目类别:
-
资助金额:$6.43万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:10221402
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:10225047
-
项目类别:
-
资助金额:$10.52万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:9904785
-
项目类别:
-
资助金额:$430.39万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:10612720
-
项目类别:
-
资助金额:$451.45万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:10371250
-
项目类别:
-
资助金额:$448.61万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
SF Bay Area MACS/WIHS Combined Cohort Study
-
批准号:10392771
-
项目类别:
-
资助金额:$4.47万
-
财政年份:2019
-
负责人:Bradley E Aouizerat
-
依托单位:
Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection
-
批准号:10404953
-
项目类别:
-
资助金额:$56.18万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Defining the impact of injection drug use on antiretroviral therapy and HIV treatment outcomes: an (epi)genomic approach
-
批准号:9976483
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir
-
批准号:10445311
-
项目类别:
-
资助金额:$60.13万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Defining the impact of injection drug use on antiretroviral therapy and HIV treatment outcomes: an (epi)genomic approach
-
批准号:10216209
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir
-
批准号:10381865
-
项目类别:
-
资助金额:$77.63万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir
-
批准号:9762074
-
项目类别:
-
资助金额:$78.26万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection
-
批准号:10171835
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Defining the impact of injection drug use on antiretroviral therapy and HIV treatment outcomes: an (epi)genomic approach
-
批准号:10448415
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2018
-
负责人:Bradley E Aouizerat
-
依托单位:
Characterization of and Treatment for Chemotherapy Neuropathy
-
批准号:8719051
-
项目类别:
-
资助金额:$126.03万
-
财政年份:2011
-
负责人:Bradley E Aouizerat
-
依托单位:
Characterization of and Treatment for Chemotherapy Neuropathy
-
批准号:8539315
-
项目类别:
-
资助金额:$126.8万
-
财政年份:2011
-
负责人:Bradley E Aouizerat
-
依托单位:
Characterization of and Treatment for Chemotherapy Neuropathy
-
批准号:8100799
-
项目类别:
-
资助金额:$138.76万
-
财政年份:2011
-
负责人:Bradley E Aouizerat
-
依托单位:
Characterization of and Treatment for Chemotherapy Neuropathy
-
批准号:8330824
-
项目类别:
-
资助金额:$134.95万
-
财政年份:2011
-
负责人:Bradley E Aouizerat
-
依托单位:
海外基金